Antidepressive Kombinationsbehandlung bei Patienten mit schwerer depressiver Episode: Verordnungspraxis am Beispiel einer klinischen Stichprobe 2012

Zusammenfassung

Anliegen Der Einsatz antidepressiver Kombinationsbehandlungen wurde bisher nur in wenigen Studien untersucht.

Methode Die Verschreibungspraxis antidepressiver Kombinationstherapien wurde am LVR-Klinikum Düsseldorf bei Patienten mit schwerer depressiver Episode (ICD-10 F32.2 und F33.2) retrospektiv untersucht.

Ergebnis Von 1198 stationären und teilstationären Fällen erhielten 25,1 % eine Kombination aus zwei oder mehr Antidepressiva.

Schlussfolgerung Kombinationstherapien werden häufig eingesetzt, was einem geringen Empfehlungsgrad der Behandlungsleitlinie gegenübersteht.

Abstract

Objectives Polypharmacy in the treatment of severe psychiatric disorders may include promising treatment options, yet may also be subject to additional side effects and interactions. In patients with severe depression, the prevalence of antidepressive (AD) combination treatment has not been thoroughly assessed yet.

Methods We assessed the prevalence of antidepressive combination treatment in a sample of hospital patients at the LVR-Clinic in Düsseldorf, Germany in 2012.

Results 1.198 residential or semi-residential patients were diagnosed with severe depressive episode and were treated with at least one antidepressant. 25.1 % of those received a combination of at least two antidepressants. The most frequent combination approaches were tri- and tetracyclic AD with selective serotonin reuptake inhibitors (SSRI) yet various other combination approaches were observed.

Conclusions Combination treatment is a common strategy. Future trends could be monitored via electronic prescription software, yet prospective confirmatory trials are needed to assess the rationale of different combination treatment approaches.

Schlüsselwörter

Depression, Antidepressiva - Polypharmazie - Kombinationsbehandlung - Qualitätserfassung

Keywords

depression - antidepressives - polypharmacy - combination treatment - quality assessment

• Literatur

• 1 Martin-Lopez LM, Rojo JE, Gibert K. et al. The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients. Depress Res Treat 2011; 2011: 140194
• 2 DGPPN, KBV, AWMF. et al. für die Leitliniengruppe Unipolare Depression, Hrsg. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. Berlin, Heidelberg: Springer; 2015
• 3 Bauer M, Pfennig A, Severus E. et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 2013; 14: 334-385
• 4 Lopes Rocha F, Fuzikawa C, Riera R. et al. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. J Clin Psychopharmacol 2012; 32: 278-281
• 5 Rush AJ, Trivedi MH, Stewart JW. et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011; 168: 689-701
• 6 Blier P, Ward HE, Tremblay P. et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010; 167: 281-288
• 7 Lopes Rocha F, Fuzikawa C, Riera R. et al. Antidepressant combination for major depression in incomplete responders – a systematic review. J Affect Disord 2013; 144: 1-6
• 8 Galling B, Calsina Ferrer A, Abi Zeid Daou M. et al. Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis. Expert opinion on drug safety 2015; 14: 1587-1608
• 9 Schmauss M, Messer T. Kombination von Antidepressiva – eine sinnvolle Behandlungsstrategie bei therapieresistenten Depressionen?. Fortschr Neurol Psychiatr 2009; 77: 316-325
• 10 Horgan D, Dodd S. Combination antidepressants – use by GPs and psychiatrists. Aust Fam Physician 2011; 40: 397-400
• 11 Lam RW, Wan DD, Cohen NL. et al. Combining antidepressants for treatment-resistant depression: a review. J Clin Psychiatry 2002; 63: 685-693
• 12 Grohmann R, Engel RR, Geissler KH. et al. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry 2004; 37 (Suppl. 01) S27-S38
• 13 Linde K, Berner M, Egger M. et al. St John’s wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 2005; 186: 99-107
• 14 Grobler AC, Matthews G, Molenberghs G. The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder. Psychopharmacol 2014; 231: 1987-1999
• 15 Härter M, Sitta P, Keller F. et al. Stationäre psychiatrisch-psychotherapeutische Depressionsbehandlung Prozess- und Ergebnisqualität anhand eines Modellprojekts in Baden-Württemberg. Nervenarzt 2004; 75: 1083-1091
• 16 Messer T, Schmauss M. Polypharmazie in der Behandlung psychischer Erkrankungen. Wien, New York: Springer; 2006
• 17 Moller HJ, Seemuller F, Schennach-Wolff R. et al. History, background, concepts and current use of comedication and polypharmacy in psychiatry. Int J Neuropsychopharmacol 2014; 17: 983-996